In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.
Publication
, Journal Article
Pisetsky, DS
Published in: Annals of internal medicine
July 2024
Rech J, Tascilar K, Hagen M, et al. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet. 2024;403:850-859. 38364841.
Duke Scholars
Published In
Annals of internal medicine
DOI
EISSN
1539-3704
ISSN
0003-4819
Publication Date
July 2024
Volume
177
Issue
7
Start / End Page
JC79
Related Subject Headings
- Risk Factors
- Randomized Controlled Trials as Topic
- Multicenter Studies as Topic
- Middle Aged
- Male
- Inflammation
- Humans
- General & Internal Medicine
- Female
- Double-Blind Method
Citation
APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S. (2024). In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo. Annals of Internal Medicine, 177(7), JC79. https://doi.org/10.7326/annals-24-00740-jc
Pisetsky, David S. “In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.” Annals of Internal Medicine 177, no. 7 (July 2024): JC79. https://doi.org/10.7326/annals-24-00740-jc.
Pisetsky DS. In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo. Annals of internal medicine. 2024 Jul;177(7):JC79.
Pisetsky, David S. “In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.” Annals of Internal Medicine, vol. 177, no. 7, July 2024, p. JC79. Epmc, doi:10.7326/annals-24-00740-jc.
Pisetsky DS. In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo. Annals of internal medicine. 2024 Jul;177(7):JC79.
Published In
Annals of internal medicine
DOI
EISSN
1539-3704
ISSN
0003-4819
Publication Date
July 2024
Volume
177
Issue
7
Start / End Page
JC79
Related Subject Headings
- Risk Factors
- Randomized Controlled Trials as Topic
- Multicenter Studies as Topic
- Middle Aged
- Male
- Inflammation
- Humans
- General & Internal Medicine
- Female
- Double-Blind Method